4.8 Article

Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer

Journal

ONCOGENE
Volume 38, Issue 27, Pages 5339-5355

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41388-019-0805-7

Keywords

-

Funding

  1. Fondazione Umberto Veronesi
  2. Associazione Italiana Ricerca sul Cancro (AIRC) [8797]
  3. AIRC
  4. Fondazione Cassa di Risparmio di Firenze [19515]
  5. Istituto Toscano Tumori [0203607]
  6. Interuniversity Attraction Pole from Belspo [UP7-03]
  7. Action de Recherche Concertee from the Communaute Francaise de Belgique [ARC 14/19-058]
  8. Belgian Fonds National de la Recherche Scientifique (F.R.S. FNRS)
  9. Programma operativo regionale Obiettivo Competitivita regionale e occupazione della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale 2007-2013 (POR CReO FESR 2007-2013)

Ask authors/readers for more resources

Cancer-associated fibroblasts (CAFs) are the major cellular stromal component of many solid tumors. In prostate cancer (PCa), CAFs establish a metabolic symbiosis with PCa cells, contributing to cancer aggressiveness through lactate shuttle. In this study, we report that lactate uptake alters the NAD(+)/NADH ratio in the cancer cells, which culminates with SIRT1-dependent PGC-1 alpha activation and subsequent enhancement of mitochondrial mass and activity. The high exploitation of mitochondria results in tricarboxylic acid cycle deregulation, accumulation of oncometabolites and in the altered expression of mitochondrial complexes, responsible for superoxide generation. Additionally, cancer cells hijack CAF-derived functional mitochondria through the formation of cellular bridges, a phenomenon that we observed in both in vitro and in vivo PCa models. Our work reveals a crucial function of tumor mitochondria as the energy sensors and transducers of CAF-dependent metabolic reprogramming and underscores the reliance of PCa cells on CAF catabolic activity and mitochondria trading.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available